{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T14:09:30Z","timestamp":1793542170656,"version":"4.5.0"},"reference-count":263,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro (AIRC)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["17216"],"award-info":[{"award-number":["17216"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"AIRC","doi-asserted-by":"publisher","award":["18999"],"award-info":[{"award-number":["18999"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.pharmthera.2017.02.041","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T15:30:43Z","timestamp":1487777443000},"page":"133-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":541,"special_numbering":"C","title":["Cannabidiol: State of the art and new challenges for therapeutic applications"],"prefix":"10.1016","volume":"175","author":[{"given":"Simona","family":"Pisanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Malfitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ciaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lamberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Ranieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Cuomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Faggiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Proto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Laezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Bifulco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2017.02.041_bb0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ceca.2015.02.001","article-title":"Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes","volume":"57","author":"Ali","year":"2015","journal-title":"Cell Calcium"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0010","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1038\/ncomms6639","article-title":"Enrichment of CD56(dim)KIR+ CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients","volume":"5","author":"Ali","year":"2014","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pnpbp.2012.10.024","article-title":"Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test","volume":"41","author":"Almeida","year":"2013","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0020","first-page":"7","article-title":"Cannabis sativa: The plant of the thousand and one molecules","volume":"4","author":"Andre","year":"2016","journal-title":"Frontiers in Plant Science"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0025","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2174\/092986711794940888","article-title":"Cannabinoids: occurrence and medicinal chemistry","volume":"18","author":"Appendino","year":"2011","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0030","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1021\/np8002673","article-title":"Antibacterial cannabinoids from Cannabis sativa: a structure-activity study","volume":"71","author":"Appendino","year":"2008","journal-title":"Journal of Natural Products"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0035","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/jid.2015.45","article-title":"Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death","volume":"135","author":"Armstrong","year":"2015","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2005.09.050","article-title":"The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy","volume":"47","author":"Asbun","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0045","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00109-011-0856-x","article-title":"Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer","volume":"90","author":"Aviello","year":"2012","journal-title":"Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0055","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/mol.116.103465","article-title":"Antagonism of dopamine receptor 2 long affects cannabinoid receptor 1 signaling in a cell culture model of striatal medium spiny projection neurons","volume":"89","author":"Bagher","year":"2016","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.phrs.2009.04.003","article-title":"Endocannabinoids and cardiac contractile function: pathophysiological implications","volume":"60","author":"B\u00e1tkai","year":"2009","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0065","doi-asserted-by":"crossref","first-page":"46188","DOI":"10.1074\/jbc.M307258200","article-title":"G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current","volume":"278","author":"Begg","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(25)00026-2","article-title":"What is synergy?","volume":"41","author":"Berenbaum","year":"1989","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0075","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0080","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm0602-547","article-title":"Targeting the endocannabinoid system in cancer therapy: A call for further research","volume":"8","author":"Bifulco","year":"2002","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.15252\/embr.201439742","article-title":"Medicinal use of cannabis in Europe: The fact that more countries legalize the medicinal use of cannabis should not become an argument for unfettered and uncontrolled use","volume":"16","author":"Bifulco","year":"2015","journal-title":"EMBO Reports"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0090","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0095","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1096\/fj.02-0795fje","article-title":"Inhibition of tumor angiogenesis by cannabinoids","volume":"17","author":"Bl\u00e1zquez","year":"2003","journal-title":"FASEB Journal"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0100","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1158\/0008-5472.CAN-03-3927","article-title":"Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas","volume":"64","author":"Bl\u00e1zquez","year":"2004","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0110","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1111\/bph.12866","article-title":"Endothelial atypical cannabinoid receptor: Do we have enough evidence?","volume":"171","author":"Bondarenko","year":"2014","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0115","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.freeradbiomed.2011.01.007","article-title":"Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress","volume":"51","author":"Booz","year":"2011","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/phar.1187","article-title":"The pharmacologic and clinical effects of medical cannabis","volume":"33","author":"Borgelt","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0125","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00109-009-0512-x","article-title":"Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis","volume":"87","author":"Borrelli","year":"2009","journal-title":"Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.11607\/ofph.1274","article-title":"The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: A systematic review","volume":"29","author":"Boychuk","year":"2015","journal-title":"Journal of Oral & Facial Pain and Headache"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0140","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3182563b19","article-title":"Patterns of treatment response in newly diagnosed epilepsy","volume":"78","author":"Brodie","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0145","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0707481","article-title":"Novel cannabinoid receptors","volume":"52","author":"Brown","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0150","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jep.2010.11.035","article-title":"Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiplesclerosis","volume":"133","author":"Buccellato","year":"2011","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-012-2878-7","article-title":"Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats","volume":"226","author":"Campos","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phrs.2016.01.033","article-title":"Cannabidiol, neuroprotection and neuropsychiatric disorders","volume":"112","author":"Campos","year":"2016","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/rej.2009.0993","article-title":"Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications","volume":"13","author":"Candore","year":"2010","journal-title":"Rejuvenation Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0170","doi-asserted-by":"crossref","first-page":"417S","DOI":"10.1002\/j.1552-4604.1981.tb02622.x","article-title":"Hypnotic and antiepileptic effects of cannabidiol","volume":"21","author":"Carlini","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0175","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI200316116","article-title":"Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors","volume":"111","author":"Casanova","year":"2003","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0195","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/jcpt.12179","article-title":"Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: A case series","volume":"39","author":"Chagas","year":"2014","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0200","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881114550355","article-title":"Effects of cannabidiol in the treatment of patients with Parkinson's disease: An exploratory double-blind trial","volume":"28","author":"Chagas","year":"2014","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0205","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","article-title":"Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe\/PS1\u2206E9 mice","volume":"231","author":"Cheng","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0210","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3233\/JAD-140921","article-title":"Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice","volume":"42","author":"Cheng","year":"2014","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0215","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrd4506","article-title":"Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: The force awakens","volume":"14","author":"Childs","year":"2015","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2008.09.004","article-title":"Caspase-mediated cleavage of ATG6\/Beclin-1 links apoptosis to autophagy in HeLa cells","volume":"274","author":"Cho","year":"2009","journal-title":"Cancer Letters"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2014.07.003","article-title":"N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice","volume":"89","author":"Ciaglia","year":"2014","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0230","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/ptr.2806","article-title":"Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress","volume":"23","author":"Comelli","year":"2009","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0235","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-G","article-title":"Controlled clinical trial of cannabidiol in Huntington's disease","volume":"40","author":"Consroe","year":"1991","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0240","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.bjp.0705920","article-title":"Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation","volume":"143","author":"Costa","year":"2004","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0245","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2006.11.006","article-title":"The non-psychoactive Cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain","volume":"556","author":"Costa","year":"2007","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0250","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0255","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2174\/1871527314666150909113930","article-title":"Cannabidiol and sodium nitroprusside: Two novel neuromodulatory pharmacological interventions to treat and prevent psychosis","volume":"14","author":"Crippa","year":"2015","journal-title":"CNS & Neurological Disorders Drug Targets"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0260","first-page":"S56","article-title":"Therapeutical use of the cannabinoids in psychiatry","volume":"32","author":"Crippa","year":"2010","journal-title":"Revista Brasileira de Psiquiatria"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb9000","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12035-013-8514-7","article-title":"Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection","volume":"49","author":"da Silva","year":"2014","journal-title":"Molecular Neurobiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2017.02.041_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028159","article-title":"Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis","volume":"6","author":"De Filippis","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0280","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1476-5381.2012.02027.x","article-title":"Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: Pro-apoptotic effects and underlying mechanisms","volume":"168","author":"De Petrocellis","year":"2013","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0300","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: An open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0310","doi-asserted-by":"crossref","first-page":"9537","DOI":"10.1523\/JNEUROSCI.1942-07.2007","article-title":"Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity","volume":"27","author":"Dirikoc","year":"2007","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0315","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1152\/ajpheart.00098.2007","article-title":"Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury","volume":"293","author":"Durst","year":"2007","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0320","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pbb.2010.03.004","article-title":"Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L","volume":"95","author":"El-Alfy","year":"2010","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0325","article-title":"TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer","author":"Elbaz","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0330","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.molonc.2014.12.010","article-title":"Modulation of the tumor microenvironment and inhibition of EGF\/EGFR pathway: Novel anti-tumor mechanisms of cannabidiol in breast cancer","volume":"9","author":"Elbaz","year":"2015","journal-title":"Molecular Oncology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0335","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2353\/ajpath.2006.050500","article-title":"Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes","volume":"168","author":"El-Remessy","year":"2006","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0345","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1111\/j.1528-1157.1995.tb01648.x","article-title":"Concepts of epilepsy","volume":"36","author":"Engel","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0350","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0733-8627(20)30386-2","article-title":"Overview of seizures","volume":"12","author":"Engel","year":"1994","journal-title":"Emergency Medicine Clinics of North America"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0355","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt\/beta-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito","year":"2006","journal-title":"Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0360","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neulet.2006.01.047","article-title":"Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement","volume":"399","author":"Esposito","year":"2006","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0365","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0375","first-page":"1233","article-title":"Hypoxia increases AP-1 binding activity by enhancing capacitative Ca2+ entry in human pulmonary artery endothelial cells","volume":"285","author":"Fantozzi","year":"2003","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0380","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2125.2012.04341.x","article-title":"Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?","volume":"75","author":"Fern\u00e1ndez-Ruiz","year":"2013","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0385","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.semcancer.2007.12.008","article-title":"The endocannabinoid system in cancer-potential therapeutic target?","volume":"18","author":"Flygare","year":"2008","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0390","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.etap.2013.04.018","article-title":"Cardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicity","volume":"36","author":"Fouad","year":"2013","journal-title":"Environmental Toxicology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0395","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1056\/NEJMra1407304","article-title":"Cannabinoids in the treatment of epilepsy","volume":"373","author":"Friedman","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0400","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0405","first-page":"20","article-title":"Cannabichromene, a new active principle in hashish","author":"Gaoni","year":"1966","journal-title":"Chemical Communications"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0410","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","article-title":"Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties","volume":"1134","author":"Garc\u00eda-Arencibia","year":"2007","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0415","series-title":"17th Annual Symposium on the Cannabinoids","first-page":"206","article-title":"Cannabigerol behaves as a partial agonist at both CB1 and CB2 receptors","author":"Gauson","year":"2007"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0425","first-page":"4906","article-title":"Purified cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis","volume":"19","author":"Giacoppo","year":"2015","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0430","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/228134a0","article-title":"Preliminary experiments on the chemistry and pharmacology of cannabis","volume":"228","author":"Gill","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009270.pub3","article-title":"Cannabinoids for epilepsy","volume":"3","author":"Gloss","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0440","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2015.01.015","article-title":"Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol","volume":"164","author":"Gomes","year":"2015","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0445","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0450","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0460","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1476-5381.2011.01327.x","article-title":"The endocannabinoid system and cancer: Therapeutic implication","volume":"163","author":"Guindon","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0465","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc1188","article-title":"Cannabinoids: Potential anticancer agents","volume":"3","author":"Guzm\u00e1n","year":"2003","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0470","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0475","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/00498259009046849","article-title":"Metabolites of cannabidiol identified in human urine","volume":"20","author":"Harvey","year":"1990","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0485","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bcp.2014.07.014","article-title":"Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1","volume":"92","author":"Haustein","year":"2014","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0490","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1248\/bpb.32.1538","article-title":"Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanism","volume":"32","author":"Hayakawa","year":"2009","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0500","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1471-4159.2007.04565.x","article-title":"Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism","volume":"102","author":"Hayakawa","year":"2007","journal-title":"Journal of Neurochemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2017.02.041_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018281","article-title":"Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol","volume":"6","author":"Hegde","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0510","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.1401844","article-title":"Critical role of mast cells and peroxisome proliferator-activated receptor \u03b3 in the induction of Myeloid-derived suppressor cells by marijuana cannabidiol in vivo","volume":"194","author":"Hegde","year":"2015","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0515","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jconrel.2012.05.003","article-title":"Poly-epsilon-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy","volume":"161","author":"Hern\u00e0n P\u00e9rez de la Ossa","year":"2012","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10.1016\/j.pharmthera.2017.02.041_bb0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054795","article-title":"Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme","volume":"8","author":"Hern\u00e0n P\u00e9rez de la Ossa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0525","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1471-4159.2010.06783.x","article-title":"Microglial activation depends on beta-amyloid conformation: Role of the formylpeptide receptor 2","volume":"114","author":"Heurtaux","year":"2010","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0545","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/bph.13368","article-title":"Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPAR\u03b3 and 5-HT1A receptors","volume":"173","author":"Hind","year":"2016","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0550","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5698\/1535-7511-15.6.313","article-title":"Finding the lesser of two evils: Treating refractory status epilepticus","volume":"15","author":"Hirsch","year":"2015","journal-title":"Epilepsy Currents"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0555","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/sj.bjp.0705160","article-title":"Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery","volume":"138","author":"Ho","year":"2003","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0560","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bjp.0707467","article-title":"The multidrug transporter ABCG2(BCRP) is inhibited by plant-derived cannabinoids","volume":"152","author":"Holland","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0565","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2011.08.013","article-title":"Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats","volume":"62","author":"Hsiao","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0570","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1152\/ajpcell.00474.2004","article-title":"Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production","volume":"288","author":"Hwang","year":"2005","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0575","first-page":"99","article-title":"Cannabidiol-induced lymphopenia does not involve NKT and NK cells","volume":"60","author":"Ignatowska-Jankowska","year":"2009","journal-title":"Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0585","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2015.01.033","article-title":"A systematic review of the antipsychotic properties of cannabidiol in humans","volume":"162","author":"Iseger","year":"2015","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0590","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1755-5949.2008.00065.x","article-title":"Cannabidiol: A promising drug for neurodegenerative disorders?","volume":"15","author":"Iuvone","year":"2009","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0595","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","article-title":"Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, onbeta-amyloid-induced toxicity in PC12 cells","volume":"89","author":"Iuvone","year":"2004","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0605","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.phrs.2009.03.008","article-title":"Cannabinoids in intestinal inflammation and cancer","volume":"60","author":"Izzo","year":"2009","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0615","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson","year":"2010","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0620","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1124\/jpet.109.159145","article-title":"Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo","volume":"332","author":"Jones","year":"2010","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0625","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/j.1476-5381.2011.01461.x","article-title":"Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and \u03949-tetrahydrocannabinol in BV-2 microglial cells","volume":"165","author":"Juknat","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0630","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bph.13345","article-title":"GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis","volume":"173","author":"Kargl","year":"2016","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0635","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/1547691X.2012.741628","article-title":"Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL\/6 mice","volume":"10","author":"Karmaus","year":"2013","journal-title":"Journal of Immunotoxicology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0640","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00210-006-0033-x","article-title":"Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors","volume":"372","author":"Kathmann","year":"2006","journal-title":"Naunyn-Schmiedebergs Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0645","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-3-319-20825-1_10","article-title":"Cannabis and Endocannabinoid Signaling in Epilepsy","volume":"231","author":"Katona","year":"2015","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0650","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11910-016-0635-8","article-title":"Novel approaches to optimization of levodopa therapy for Parkinson's disease","volume":"16","author":"Kianirad","year":"2016","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0655","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnen\/61.3.215","article-title":"The WHO classification of tumors of the nervous system","volume":"61","author":"Kleihues","year":"2002","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0660","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1021\/jm040042o","article-title":"Synthesis and antitumor activity of quinonoid derivatives of cannabinoids","volume":"47","author":"Kogan","year":"2004","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0665","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1158\/1535-7163.MCT-06-0039","article-title":"HU-331, a novel cannabinoid-based anticancer topoisomerase IIinhibitor","volume":"6","author":"Kogan","year":"2007","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0670","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12974-016-0603-x","article-title":"Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells","volume":"13","author":"Kozela","year":"2016","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0675","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12974-015-0273-0","article-title":"Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic Tcells","volume":"12","author":"Kozela","year":"2015","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0680","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s11481-013-9493-1","article-title":"Cannabinoids decrease the th17 inflammatory autoimmune phenotype","volume":"8","author":"Kozela","year":"2013","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0685","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1476-5381.2011.01379.x","article-title":"Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiplesclerosis-like disease in C57BL\/6 mice","volume":"163","author":"Kozela","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0690","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1074\/jbc.M109.069294","article-title":"Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta\/STAT proinflammatory pathways in BV-2 microglial cells","volume":"285","author":"Kozela","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0695","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0700","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0705","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2004.11.009","article-title":"Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease","volume":"19","author":"Lastres-Becker","year":"2005","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0710","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","article-title":"The role of microglia in amyloid clearance from the AD brain","volume":"117","author":"Lee","year":"2010","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0715","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.intimp.2008.01.018","article-title":"A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells","volume":"8","author":"Lee","year":"2008","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0720","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2009.09.045","article-title":"Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats","volume":"207","author":"Lemos","year":"2010","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0725","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1124\/jpet.106.105247","article-title":"Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma","volume":"318","author":"Ligresti","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0730","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1167\/iovs.08-2196","article-title":"Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor","volume":"49","author":"Liou","year":"2008","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0735","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/aps.2010.155","article-title":"Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity","volume":"31","author":"Liu","year":"2010","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0740","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1517\/14728222.10.5.653","article-title":"Targeting the CB2 receptor for immune modulation","volume":"10","author":"Lunn","year":"2006","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0745","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2014.03.055","article-title":"Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature","volume":"735","author":"MacIntyre","year":"2014","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0750","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.bjp.0701915","article-title":"Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors","volume":"124","author":"MacLennan","year":"1998","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0755","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2009.04.021","article-title":"Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation","volume":"51","author":"Magen","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0765","doi-asserted-by":"crossref","first-page":"9561","DOI":"10.1073\/pnas.160105897","article-title":"The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis","volume":"97","author":"Malfait","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0770","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/14728222.2011.553606","article-title":"Update on the endocannabinoid system as an anticancer target","volume":"15","author":"Malfitano","year":"2011","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0780","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1158\/1535-7163.MCT-09-0407","article-title":"Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival","volume":"9","author":"Marcu","year":"2010","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0785","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbr.2015.02.023","article-title":"Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences","volume":"286","author":"Marinho","year":"2015","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0790","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: Relevance to Alzheimer's disease","volume":"79","author":"Mart\u00edn-Moreno","year":"2011","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0800","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.103.061002","article-title":"Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines","volume":"308","author":"Massi","year":"2004","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0805","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1471-4159.2007.05073.x","article-title":"5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psycoactivecannabidiol","volume":"104","author":"Massi","year":"2008","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0810","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11060-004-5950-2","article-title":"Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells","volume":"74","author":"McAllister","year":"2005","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0815","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-010-1177-4","article-title":"Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis","volume":"129","author":"McAllister","year":"2011","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0820","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1124\/jpet.105.095992","article-title":"Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptors","volume":"316","author":"McHugh","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0825","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1124\/mol.106.023937","article-title":"Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression","volume":"70","author":"McKallip","year":"2006","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0830","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.102.033506","article-title":"Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo","volume":"302","author":"McKallip","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0835","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","article-title":"Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors","volume":"59","author":"Mecha","year":"2013","journal-title":"Neurobiology of Disease"},{"issue":"3","key":"10.1016\/j.pharmthera.2017.02.041_bb0840","article-title":"Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress","volume":"28","author":"Mecha","year":"2012","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0845","first-page":"2073","volume":"Vol. 19","author":"Mechoulam","year":"1963"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0850","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2174\/1871527313666140612114838","article-title":"Antidepressant-like and anxiolytic-like effects of cannabidiol: A chemical compound of Cannabis sativa","volume":"13","author":"de Mello Schier","year":"2014","journal-title":"CNS & Neurological Disorders Drug Targets"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0855","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.STR.0000163083.59201.34","article-title":"Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism","volume":"36","author":"Mishima","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0865","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tips.2012.03.002","article-title":"At the heart of the matter: The endocannabinoid system in cardiovascular function and dysfunction","volume":"33","author":"Montecucco","year":"2012","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0870","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.pnpbp.2006.06.004","article-title":"Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test","volume":"30","author":"Moreira","year":"2006","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0880","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/55.3.597","article-title":"Antineoplastic activity of cannabinoids","volume":"55","author":"Munson","year":"1975","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0885","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1016\/j.febslet.2006.04.102","article-title":"Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats","volume":"580","author":"Murillo-Rodr\u00edguez","year":"2006","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0890","doi-asserted-by":"crossref","first-page":"212","DOI":"10.18773\/austprescr.2015.072","article-title":"Medicinal cannabis","volume":"38","author":"Murnion","year":"2015","journal-title":"Australian Prescriber"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0900","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/ijc.29573","article-title":"Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner","volume":"137","author":"Nabissi","year":"2015","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0910","first-page":"455","article-title":"Treatment of Crohn's disease with cannabis: An observational study","volume":"13","author":"Naftali","year":"2011","journal-title":"Israel Medical Association Journal"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0915","first-page":"1748","article-title":"Effects of cannabinoids on macromolecular synthesis and replication of cultured lymphocytes","volume":"36","author":"Nahas","year":"1977","journal-title":"Federation Proceedings"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0925","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1212\/WNL.0b013e31822cfc90","article-title":"Incidence of epilepsy: A systematic review and meta-analysis","volume":"77","author":"Ngugi","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0930","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.jcp.0000125688.05091.8f","article-title":"Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults","volume":"24","author":"Nicholson","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0935","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0940","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1124\/mol.63.3.699","article-title":"Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor","volume":"63","author":"Offert\u00e1ler","year":"2003","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0945","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1124\/jpet.105.095828","article-title":"Further characterization of the time-dependent vascular effects of delta9-tetrahydrocannabinol","volume":"317","author":"O'Sullivan","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0950","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2009.03.010","article-title":"Time-dependent vascular actions of cannabidiol in the rat aorta","volume":"612","author":"O'Sullivan","year":"2009","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0955","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbrc.2005.09.121","article-title":"Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma","volume":"337","author":"O'Sullivan","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0960","first-page":"139","article-title":"Endocannabinoids, cannabinoid receptors and inflammatory stress: An interview with Dr. P\u00e1l [corrected] Pacher. Interviewed by Helene F. Rosenberg","volume":"82","author":"Pacher","year":"2007","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0970","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.108.147181","article-title":"Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative\/nitrosative stress, inflammation, and cell death","volume":"328","author":"Pan","year":"2009","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0975","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00001756-200204160-00006","article-title":"Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats","volume":"13","author":"Parker","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0980","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1476-5381.2009.00622.x","article-title":"N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels","volume":"160","author":"Parmar","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0985","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/14737175.8.1.37","article-title":"Cannabinoids as potential new therapy for the treatment of gliomas","volume":"8","author":"Parolaro","year":"2008","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0990","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1054\/plef.2001.0355","article-title":"Endocannabinoids in the immune system and cancer","volume":"66","author":"Parolaro","year":"2002","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb0995","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neuropharm.2012.05.034","article-title":"Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function","volume":"63","author":"Pazos","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1000","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2013.03.027","article-title":"Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: Role of 5HT(1A) and CB2 receptors","volume":"71","author":"Pazos","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/0929867306666220401124036","article-title":"Pharmacology of cannabinoid receptor ligands","volume":"6","author":"Pertwee","year":"1999","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1010","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.lfs.2004.10.025","article-title":"Inverse agonism and neutral antagonism at cannabinoid CB1 receptors","volume":"76","author":"Pertwee","year":"2005","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1054\/plef.2001.0341","article-title":"Cannabinoid receptors and their ligands","volume":"66","author":"Pertwee","year":"2002","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(02)02624-9","article-title":"(\u2212)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens","volume":"456","author":"Pertwee","year":"2002","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1035","first-page":"1307","article-title":"The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo","volume":"76","author":"Pertwee","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1040","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","article-title":"Adverse effects of antiepileptic drugs","volume":"11","author":"Perucca","year":"2012","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0024-3205(98)00238-0","article-title":"Complex pharmacology of natural cannabinoids: Evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors","volume":"63","author":"Petitet","year":"1998","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00482-015-0089-y","article-title":"Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies","volume":"30","author":"Petzke","year":"2016","journal-title":"Der Schmerz"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2016.12.002","article-title":"Modern history of medical cannabis: From widespread use to prohibitionism and back","author":"Pisanti","year":"2017","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/jcp.20954","article-title":"Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor-suppressor efficacy","volume":"211","author":"Pisanti","year":"2007","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.beem.2009.02.001","article-title":"Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents","volume":"23","author":"Pisanti","year":"2009","journal-title":"Best Practice & Research. Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tips.2013.03.003","article-title":"The endocannabinoid signaling system in cancer","volume":"34","author":"Pisanti","year":"2013","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1075","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1182\/blood-2010-09-307355","article-title":"Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis","volume":"117","author":"Pisanti","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1080","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1096\/fj.02-1129fje","article-title":"Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: Actions on signals involved in angiogenesis and metastasis","volume":"17","author":"Portella","year":"2003","journal-title":"FASEB Journal"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11481-014-9575-8","article-title":"Neuroprotection in experimental autoimmune encephalomyelitis and progressive multiple sclerosis by cannabis-based cannabinoids","volume":"10","author":"Pryce","year":"2014","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1090","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1152\/ajpheart.00236.2007","article-title":"Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption","volume":"293","author":"Rajesh","year":"2007","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1095","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","article-title":"Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy","volume":"56","author":"Rajesh","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1100","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1096\/fj.11-198184","article-title":"Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1","volume":"26","author":"Ramer","year":"2012","journal-title":"FASEB Journal"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bcp.2014.06.017","article-title":"Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells","volume":"91","author":"Ramer","year":"2014","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1158\/1535-7163.MCT-12-0335","article-title":"COX-2 and PPAR-\u03b3 confer cannabidiol-induced apoptosis of human lung cancer cells","volume":"12","author":"Ramer","year":"2013","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.bcp.2009.11.007","article-title":"Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1","volume":"79","author":"Ramer","year":"2010","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1120","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1007\/s11095-010-0219-2","article-title":"Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells","volume":"27","author":"Ramer","year":"2010","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0163-7258(02)00258-9","article-title":"Cardiovascular effects of cannabinoids","volume":"95","author":"Randall","year":"2002","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/08923973.2014.976794","article-title":"Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury","volume":"37","author":"Ribeiro","year":"2015","journal-title":"Immunopharmacology and Immunotoxicology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2011.12.043","article-title":"Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor","volume":"678","author":"Ribeiro","year":"2012","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11060-013-1277-1","article-title":"Systematic review of the literature on clinical and experimental trials on the antitumor effects ofcannabinoids in gliomas","volume":"116","author":"Rocha","year":"2014","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1150","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00213-007-0970-1","article-title":"The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat","volume":"196","author":"Rock","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1155","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s13311-015-0375-5","article-title":"Cannabinoids and epilepsy","volume":"12","author":"Rosenberg","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1160","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0041-008X(81)90122-8","article-title":"Toxicity of short-term administration of cannabinoids to rhesus monkeys","volume":"58","author":"Rosenkrantz","year":"1981","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0041-008X(79)90421-6","article-title":"Acute and subacute inhalation toxicity of Turkish marihuana, cannabichromene, and cannabidiol in rats","volume":"48","author":"Rosenkrantz","year":"1979","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1170","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1175","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1180","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","article-title":"A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol","volume":"66","author":"Russo","year":"2006","journal-title":"Medical Hypotheses"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1185","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1523\/JNEUROSCI.4212-08.2009","article-title":"Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels","volume":"29","author":"Ryan","year":"2009","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2004.10.003","article-title":"The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro","volume":"159","author":"Sacerdote","year":"2005","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1195","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/jnr.22682","article-title":"Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease","volume":"89","author":"Sagredo","year":"2011","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1200","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nri3086","article-title":"Microglial cell origin and phenotypes in health and disease","volume":"11","author":"Saijo","year":"2011","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1205","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.4161\/auto.5.7.9508","article-title":"TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action","volume":"5","author":"Salazar","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/00498259009047153","article-title":"Identification of glucose conjugates as major urinary metabolites of cannabidiol in the dog","volume":"20","author":"Samara","year":"1990","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1215","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/bdd.2510110906","article-title":"Pharmacokinetics of urinary metabolites of cannabidiol in the dog","volume":"11","author":"Samara","year":"1990","journal-title":"Biopharmaceutics & Drug Disposition"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1220","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF03189976","article-title":"Metabolism of cannabidiol by the rat","volume":"16","author":"Samara","year":"1991","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1225","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0090-9556(25)08556-3","article-title":"Microsomal metabolism of the 1\u2033,1\u2033-dimethylheptyl analogue of cannabidiol: Relative percentage of monohydroxy metabolites in four species","volume":"18","author":"Samara","year":"1990","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1230","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1528-1157.1997.tb01148.x","article-title":"ILAE commission report. The epidemiology of the epilepsies: Future directions. International League against epilepsy","volume":"38","author":"Sander","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1235","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tiv.2015.11.004","article-title":"The neuroprotection of cannabidiol against MPP+-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease","volume":"30","author":"Santos","year":"2015","journal-title":"Toxicology In Vitro"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","article-title":"Contribution of inflammatory processes to Alzheimer's disease: Molecular mechanisms","volume":"24","author":"Sastre","year":"2006","journal-title":"International Journal of Developmental Neuroscience"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1245","first-page":"51","article-title":"Cannabidiol as a potential treatment for psychosis","volume":"Vol. 24","author":"Schubart","year":"2014"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1250","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1158\/1535-7163.MCT-14-0402","article-title":"The combination of cannabidiol and \u03949-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model","volume":"13","author":"Scott","year":"2014","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1255","first-page":"5827","article-title":"Inhibiting heat shock proteins can potentiate the cytotoxic effect of cannabidiol in human glioma cells","volume":"35","author":"Scott","year":"2015","journal-title":"Anticancer Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1260","first-page":"4373","article-title":"Enhancing the activity of cannabidiol and other cannabinoids in vitro through modifications to drug combinations and treatment schedules","volume":"33","author":"Scott","year":"2013","journal-title":"Anticancer Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1265","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1270","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00019052-200208000-00009","article-title":"Clinical aspects of Parkinson disease","volume":"15","author":"Sethi","year":"2002","journal-title":"Current Opinion in Neurology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1275","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4236\/pp.2014.58091","article-title":"In vitro anticancer activity of plant-derived cannabidiol on prostate cancer cell lines","volume":"5","author":"Sharma","year":"2014","journal-title":"Pharmacology & Pharmacy"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1280","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000443890","article-title":"Prohedonic effect of cannabidiol in a rat model of depression","volume":"73","author":"Shoval","year":"2016","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1285","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-3565(25)20744-3","article-title":"Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands","volume":"278","author":"Showalter","year":"1996","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1290","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1535-7163.MCT-10-1100","article-title":"Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy","volume":"10","author":"Shrivastava","year":"2011","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1300","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/clc.21962","article-title":"Cannabinoids and atherosclerotic coronary heart disease","volume":"35","author":"Singla","year":"2012","journal-title":"Clinical Cardiology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1305","first-page":"659","article-title":"Effects of cannabinoids on the perfused rat heart","volume":"14","author":"Smiley","year":"1976","journal-title":"Research Communications in Chemical Pathology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1310","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbr.2010.05.004","article-title":"Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors","volume":"213","author":"Soares Vde","year":"2010","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1315","doi-asserted-by":"crossref","unstructured":"Solinas, M., Massi, P., Cantelmo, A. R., Cattaneo, M. G., Cammarota, R., Bartolini, D. et al. (2012). Cannabidiol inhibits angiogenesis by multiple mechanisms. British Journal of Pharmacology, 167, 1218-1231.","DOI":"10.1111\/j.1476-5381.2012.02050.x"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076918","article-title":"Cannabidiol, a non-psychoactivecannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitargeteffect","volume":"8","author":"Solinas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1325","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1158\/0008-5472.CAN-12-1943","article-title":"Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target","volume":"73","author":"Soroceanu","year":"2013","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1330","first-page":"3799","article-title":"Induction ofapoptosis by cannabinoids in prostate and colon cancer cells is phosphatasedependent","volume":"31","author":"Sreevalsan","year":"2011","journal-title":"Anticancer Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1335","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2125.2012.04351.x","article-title":"Is the cardiovascular system a therapeutic target for cannabidiol?","volume":"75","author":"Stanley","year":"2013","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1340","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/cvr\/cvv179","article-title":"Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation","volume":"107","author":"Stanley","year":"2015","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1345","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4140\/TCP.n.2014.469","article-title":"Multiple sclerosis: A review of the disease and treatment options","volume":"29","author":"Sturm","year":"2014","journal-title":"Consultant Pharmacist"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1350","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1167\/iovs.14-14879","article-title":"Role of endothelium in abnormal cannabidiol-induced vasoactivity in retinal arterioles","volume":"56","author":"Su","year":"2015","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1355","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1248\/bpb.34.1252","article-title":"Cannabidiol-2\u2032,6\u2032-dimethyl ether as an effective protector of 15-lipoxygenase-mediated low-density lipoprotein oxidation in vitro","volume":"34","author":"Takeda","year":"2011","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1360","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2006.01.021","article-title":"The various aggregation states of \u03b2-amyloid 1\u201342 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression","volume":"41","author":"Tamagno","year":"2006","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1365","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1370","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3565(24)37365-3","article-title":"Comparative receptor binding analyses of cannabinoid agonists and antagonists","volume":"285","author":"Thomas","year":"1998","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1375","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1535-7163.MCT-10-0688","article-title":"A combined preclinical therapy of cannabinoids and temozolomideagainst glioma","volume":"10","author":"Torres","year":"2011","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1380","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: An immune or neurodegenerative disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1390","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/sj.bjp.0706134","article-title":"Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism","volume":"144","author":"Vaccani","year":"2005","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1400","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-8-5","article-title":"Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: An intravital microscopy study","volume":"8","author":"Valdepe\u00f1as","year":"2011","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1410","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nrc3247","article-title":"Towards the use of cannabinoids as antitumour agents","volume":"12","author":"Velasco","year":"2012","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1415","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/978-3-319-20825-1_16","article-title":"Endocannabinoids and cancer","volume":"231","author":"Velasco","year":"2015","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1420","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0040-4039(01)87494-3","article-title":"Cannabidivarin, a new hashish constituent","volume":"3","author":"Vollner","year":"1969","journal-title":"Tetrahedron Letters"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1430","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1476-5381.2010.00755.x","article-title":"Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion","volume":"160","author":"Walsh","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1440","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","article-title":"Nonpsychotropic cannabinoid receptors regulate microglial cell migration","volume":"23","author":"Walter","year":"2003","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1450","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/08916930500356674","article-title":"Cannabidiol lowers incidence of diabetes in non-obese diabetic mice","volume":"39","author":"Weiss","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1455","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2007.06.029","article-title":"Cannabidiol arrests onset of autoimmune diabetes in NOD mice","volume":"54","author":"Weiss","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1460","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2337\/db08-0329","article-title":"Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy","volume":"58","author":"Westermann","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1465","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/jpet.114.217125","article-title":"Cannabidiol improves vasorelaxation in Zucker diabetic fatty rats through cyclooxygenase activation","volume":"351","author":"Wheal","year":"2014","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1480","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2009.16","article-title":"Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria","volume":"1","author":"Wirawan","year":"2010","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1485","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.taap.2007.09.012","article-title":"Cannabidiol-induced apoptosis in primary lymphocytes is associated with oxidative stress-dependent activation of caspase-8","volume":"226","author":"Wu","year":"2008","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2017.02.041_bb1490","doi-asserted-by":"crossref","first-page":"509.e1","DOI":"10.1016\/j.urology.2010.03.029","article-title":"TRPV2 activation induces apoptotic cell death in human T24 bladdercancer cells: a potential therapeutic target for bladder cancer","volume":"76","author":"Yamada","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1495","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1476-5381.2009.00579.x","article-title":"A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats","volume":"160","author":"Zakrzeska","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1500","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-neuro-070815-014038","article-title":"Beyond the CB1 receptor: Is cannabidiol the answer for disorders of motivation?","volume":"39","author":"Zlebnik","year":"2016","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1510","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.2174\/138161212802884681","article-title":"A critical review of the antipsychotic effects of cannabidiol: 30years of a translational investigation","volume":"18","author":"Zuardi","year":"2012","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1515","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1590\/S0100-879X2006000400001","article-title":"Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug","volume":"39","author":"Zuardi","year":"2006","journal-title":"Brazilian Journal of Medical and Biological Research"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1520","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1177\/0269881108096519","article-title":"Cannabidiol for the treatement of psychosis in Parkinson's disease","volume":"23","author":"Zuardi","year":"2009","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2017.02.041_bb1525","first-page":"485","article-title":"Antipsychotic effect of cannabidiol","volume":"56","author":"Zuardi","year":"1995","journal-title":"Journal of Clinical Psychiatry"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725817300657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725817300657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T15:44:33Z","timestamp":1750002273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725817300657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":263,"alternative-id":["S0163725817300657"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2017.02.041","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol: State of the art and new challenges for therapeutic applications","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2017.02.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}